Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational ...
Becker's Hospital Review27d
FDA grants fast-track status to combination influenza and COVID-19 vaccine candidates
The FDA has ... and COVID-19, according to a Dec. 16 AJMC report. These vaccine candidates combine the flu vaccine with the Novavax COVID-19 vaccine, offering a potential single shot to address ...
Nasdaq1mon
NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines
The study will compare the immunogenicity and safety of the CIC vaccine with separate administrations of Novavax’s ... COVID/flu combination vaccines. Earlier today, SNY announced that the FDA ...